ITGAE and cancer: The crucial role of CD103+ cDC1s has been further substantiated using BATF3−/− mice devoid of CD103+ cDC1s, which fail to reject immunogenic cancer cell lines and are unresponsive to immune checkpoint inhibition (17, 19, 21, 22).